Tandem Diabetes Care Inc (NASDAQ: TNDM) stock closed at $31.14 on 3/4/24 after a major increase of 12.9%. Moreover, trading volume in this advance was above average at 127% of normal. The stock has risen 6.9% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, TNDM is expected to be Value Creation neutral.
Tandem Diabetes Care has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Tandem Diabetes Care has a poor Power Rating of 26 and a very low Appreciation Score of 6, with the Lowest Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment